The first Australian trial of a new COVID medication that is set to save the lives of vulnerable immuno-suppressed patients has been launched in Brisbane.

Dr Jay Gunawardana and Dr Joshua Tobin, members of Mater Research's Blood Cancer Group led by Professor Maher Gandhi, have recently been awarded more than $375,000 in funding to further their...

Scientists at Mater Research and The University of Queensland have recently identified a potential treatment to enhance the healing of fractures among osteoporosis sufferers.

A ground-breaking Mater Research project will place health workers in Indigenous communities across Queensland and study the long-term wellbeing of 400 Aboriginal and Torres Strait Islander...